What is the appropriate renal dosing of amoxil (amoxicillin) for treating community‑acquired pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Renal Dosing of Amoxicillin for Pneumonia

For adults with community-acquired pneumonia and renal impairment, adjust amoxicillin dosing based on GFR: use 500 mg or 250 mg every 12 hours for GFR 10-30 mL/min, and 500 mg or 250 mg every 24 hours for GFR <10 mL/min, with hemodialysis patients receiving an additional dose during and after dialysis. 1

Standard Dosing in Normal Renal Function

Before addressing renal adjustments, the baseline pneumonia dosing is:

  • Healthy outpatients without comorbidities: Amoxicillin 1 g three times daily (strong recommendation) 2
  • Outpatients with comorbidities (including chronic renal disease): Amoxicillin/clavulanate 500/125 mg three times daily, 875/125 mg twice daily, or 2000/125 mg twice daily as part of combination therapy 2

Renal Dose Adjustments

The FDA label provides explicit guidance for renal impairment 1:

Moderate Renal Impairment (GFR 10-30 mL/min)

  • Dose: 500 mg or 250 mg every 12 hours
  • Severity of infection determines whether to use the higher or lower dose

Severe Renal Impairment (GFR <10 mL/min)

  • Dose: 500 mg or 250 mg every 24 hours
  • Again, infection severity guides dose selection

Hemodialysis Patients

  • Dose: 500 mg or 250 mg every 24 hours
  • Critical addition: Give supplemental dose both during and at the end of dialysis
  • This accounts for drug removal during the dialysis session 1

Important Clinical Considerations

Patients with mild renal impairment generally do not require dose reduction unless impairment is severe 1. The FDA explicitly states this, meaning you can use standard pneumonia dosing (1 g three times daily) until GFR drops below 30 mL/min.

Key Pitfall to Avoid

The 2019 ATS/IDSA guidelines specifically list chronic renal disease as a comorbidity requiring combination therapy rather than monotherapy 2. However, when renal function is severely impaired (GFR <30 mL/min), you must prioritize the FDA renal dosing adjustments over the standard pneumonia doses. This means you cannot give the full 1 g three times daily in severe renal impairment—you must reduce to the renally-adjusted doses.

Pharmacokinetic Rationale

Research confirms that renal impairment significantly decreases amoxicillin clearance and total body clearance, with a linear relationship between the drug's elimination rate and creatinine clearance 3. During hemodialysis, the half-life extends to 2.3 hours, necessitating post-dialysis supplementation 3.

Pediatric Patients

No specific renal dosing recommendations exist for pediatric patients with impaired renal function 1. Clinical judgment and consultation with pediatric nephrology/infectious disease specialists is warranted in these cases.

Practical Algorithm

  1. Assess GFR/CrCl
  2. If GFR ≥30 mL/min: Use standard pneumonia dosing (1 g TID for healthy patients, or amoxicillin/clavulanate for those with comorbidities)
  3. If GFR 10-30 mL/min: Reduce to 500 mg or 250 mg every 12 hours
  4. If GFR <10 mL/min or on hemodialysis: Reduce to 500 mg or 250 mg every 24 hours, with extra doses during/after dialysis
  5. Choose 500 mg vs 250 mg based on pneumonia severity: Use higher dose (500 mg) for more severe infections

This approach balances the need for adequate antimicrobial coverage against the risk of drug accumulation and toxicity in renal impairment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.